The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review
International Journal of Molecular Sciences · 19.06.2026 · 27 (12) · 5545
DOI: 10.3390/ijms27125545 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.06.2026. Verfasst von Joanna Robaczyńska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, …. Hauptthemen laut MEDLINE: Vitamin D, BRCA1 Protein, Breast Neoplasms. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vitamin D is a fat-soluble secosteroid essential for skeletal development and calcium homeostasis, but it also exerts pleiotropic effects on numerous biological processes via its active metabolites. Vitamin D metabolites act as steroid hormones that regulate cell-cycle progression, proliferation, differentiation, apoptosis, immune responses, and multiple intracellular signaling pathways. Moreover, they modulate the expression of genes involved in carcinogenesis. As circulating vitamin D levels are influenced by diet, fortified foods, and supplementation, they represent a potentially modifiable factor. Whether vitamin D status affects cancer risk or disease progression in carriers of pathogenic BRCA1 variants remains unclear and continues to be actively investigated. Clarifying this relationship could have significant clinical implications for risk stratification and prevention in this high-risk population. This narrative review summarizes current evidence from epidemiological, clinical, and molecular studies examining the role of vitamin D in BRCA1 pathogenic variant carriers. It also highlights key limitations in the existing literature and identifies critical directions for future research, emphasizing the need for well-designed prospective studies in representative cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, Poland.
- Department of Histology and Embryology, Medical University of Warsaw, 02-004 Warsaw, Poland.
- Department of Diagnostic Imaging and Interventional Radiology, Pomeranian Medical University Hospital, No. 1, 71-252 Szczecin, Poland.
- Department of Oncology and Chemotherapy, Pomeranian Medical University, 71-252 Szczecin, Poland.
ORCID-Profile: Joanna Robaczyńska, Milena Kiljańczyk, Maciej Maj, Adam Kiljańczyk, Cezary Cybulski, Izabela Janiuk, Jacek Gronwald, Jan Lubiński
Zitieren
APA
Robaczyńska, J., Kiljańczyk, M., Maj, M., Kiljańczyk, A., Byrski, T., Cybulski, C., Janiuk, I., Gronwald, J., & Lubiński, J. (2026). The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review. International Journal of Molecular Sciences, 27(12), 5545. https://doi.org/10.3390/ijms27125545
Vancouver
Robaczyńska J, Kiljańczyk M, Maj M, Kiljańczyk A, Byrski T, Cybulski C, et al. The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review. International Journal of Molecular Sciences. 2026;27(12):5545. doi:10.3390/ijms27125545
BibTeX
@article{Robaczyska2026,
author = {Robaczyńska, Joanna and Kiljańczyk, Milena and Maj, Maciej and Kiljańczyk, Adam and Byrski, Tomasz and Cybulski, Cezary and Janiuk, Izabela and Gronwald, Jacek and Lubiński, Jan},
title = {The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5545},
doi = {10.3390/ijms27125545}
}
EUVIMED